Ionis Pharmaceuticals Inc (IONS)
37.24
-0.56
(-1.48%)
USD |
NASDAQ |
Nov 14, 16:00
37.25
+0.01
(+0.03%)
After-Hours: 17:27
Ionis Pharmaceuticals Total Return Level: 37.80 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 37.80 |
November 12, 2024 | 37.77 |
November 11, 2024 | 38.88 |
November 08, 2024 | 39.19 |
November 07, 2024 | 38.46 |
November 06, 2024 | 39.04 |
November 05, 2024 | 38.80 |
November 04, 2024 | 38.44 |
November 01, 2024 | 38.76 |
October 31, 2024 | 38.39 |
October 30, 2024 | 39.26 |
October 29, 2024 | 39.71 |
October 28, 2024 | 40.36 |
October 25, 2024 | 39.19 |
October 24, 2024 | 38.77 |
October 23, 2024 | 38.42 |
October 22, 2024 | 38.68 |
October 21, 2024 | 39.00 |
October 18, 2024 | 39.68 |
October 17, 2024 | 38.49 |
October 16, 2024 | 39.16 |
October 15, 2024 | 37.84 |
October 14, 2024 | 38.63 |
October 11, 2024 | 38.44 |
October 10, 2024 | 37.95 |
Date | Value |
---|---|
October 09, 2024 | 38.06 |
October 08, 2024 | 37.80 |
October 07, 2024 | 37.86 |
October 04, 2024 | 37.91 |
October 03, 2024 | 37.81 |
October 02, 2024 | 39.38 |
October 01, 2024 | 39.07 |
September 30, 2024 | 40.06 |
September 27, 2024 | 40.85 |
September 26, 2024 | 41.10 |
September 25, 2024 | 40.99 |
September 24, 2024 | 41.00 |
September 23, 2024 | 41.83 |
September 20, 2024 | 42.76 |
September 19, 2024 | 42.74 |
September 18, 2024 | 42.36 |
September 17, 2024 | 41.51 |
September 16, 2024 | 40.70 |
September 13, 2024 | 42.19 |
September 12, 2024 | 41.02 |
September 11, 2024 | 42.53 |
September 10, 2024 | 42.39 |
September 09, 2024 | 48.33 |
September 06, 2024 | 46.89 |
September 05, 2024 | 48.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
25.61
Minimum
Dec 01 2021
65.27
Maximum
Dec 16 2019
44.30
Average
42.52
Median
Total Return Level Benchmarks
Biogen Inc | 165.79 |
Alnylam Pharmaceuticals Inc | 264.47 |
Biomarin Pharmaceutical Inc | 66.66 |
Amicus Therapeutics Inc | 10.38 |
Arbutus Biopharma Corp | 3.65 |